Lecture – 16 Carbohydrates I

Lecture Series on BioChemistry I by Prof.S.Dasgupta, Dept of Chemistry, IIT Kharagpur. For more details on NPTEl visit http://nptel.iitm.ac.in.
Video Rating: 4 / 5

Four Levels of Protein Structure

Learn about the different levels of protein structure – primary, secondary, tertiary, and quaternary. By Tracy Kovach. More free lessons at: http://www.khana…
Video Rating: 4 / 5

NIH awards Schiffer $7.9 million to attack drug resistance

NIH awards Schiffer .9 million to attack drug resistance
“Right now drug resistance isn't part of the drug design process; it is more of an afterthought, which is very costly to society financially and, ultimately, in human health” said Dr. Schiffer, professor of biochemistry & molecular pharmacology, and …
Read more on News from the University of Massachusetts

BTN LiveBIG: Illinois research team could revolutionize breast cancer treatment
It's Breast Cancer Awareness Month, and new research from a University of Illinois medical team could redefine the role of estrogen in the development of this deadly disease. Biochemistry professor David Shapiro and M.D.-Ph.D. student Neal Andruska …
Read more on Big Ten Network

Washington biochem students work with gamers for research
SEATTLE (NEWSCHANNEL 3) – The University of Washington is using video games to try to find a cure for some of the world's worst diseases, like ebola. Biochemistry students are joining with gamers who play Fold-It, a video game that lets players tackle …
Read more on WWMT-TV

Challenges to access foreign talent

Challenges to access foreign talent
The federal government is committed to ensuring Canadian workers have the first opportunity to fill all available jobs. While well intentioned, there remain some employers who, despite high localized unemployment, simply cannot find the skills they need.
Read more on The Guardian

Student group work essential for professional education
Freshman Colin Kimberlin, a biochemistry and diplomacy major, said: “The teacher assigns people together but she doesn't necessarily understand everyone's abilities or what they're best at when they're working together in a team environment.
Read more on Setonian

'Everyone is a scientist'
“It was a lot of work getting it done, but very fun” she said of taping the outlines of bodies on the floor, smearing fake blood everywhere and breaking Dollar Store snowflakes into shards of 'glass. … He led a presentation called “The Life of a …
Read more on Millbury-Sutton Chronicle

31. Kevin Ahern’s Biochemistry – Membrane Transport and Mitochondria

1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Download my free biochemistry book at http://biochem.science.oregonstate…
Video Rating: 5 / 5

30. Kevin Ahern’s Biochemistry – Lipids, Membranes, and Membrane Transport

mqdefault1

30.  Kevin Ahern's Biochemistry - Lipids, Membranes, and Membrane Transport

1. Contact me at kgahern@davincipress.com / Friend me on Facebook (kevin.g.ahern) 2. Download my free biochemistry book at http://biochem.science.oregonstate…

Nutrition 21, LLC Announces The Presentation Of Results Of A Nitrosigine Clinical Study At The Renowned Experimental Biology 2014 Annual Meeting

gI_59471_1stBtwoBcharts


Purchase, NY (PRWEB) May 05, 2014

Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of a new clinical study supporting Nitrosigine™ inositol-stabilized arginine silicate, titled, “A Clinical Evaluation to Determine the Safety, Pharmacokinetics and Pharmacodynamics of an Inositol-Stabilized Arginine Silicate Dietary Supplement in Healthy Adult Males.” The study will be presented today to scientists and other professionals at the acclaimed Experimental Biology 2014 annual meeting’s poster session and will be published in the FASEB (Federation of American Societies for Experimental Biology) Journal.

The clinical study demonstrated significant increases in plasma arginine levels (P<0.01) and serum silicon levels (P<0.01) after a single dose of Nitrosigine™. In addition, a significant increase in nitric oxide levels (measured as salivary nitrites) was seen after 14 days of product consumption (P<0.05). The results of the clinical study support the use of Nitrosigine™ as a bioavailable source of arginine and silicon, validating the preclinical studies and confirming Nitrosigine™ as an effective ingredient in products for sports nutrition, men’s health and cardiovascular health.

The clinical study verified Nitrosigine™ supplementation increased nitric oxide (NO) levels with a significant change in NO levels between the first treatment visit and after 14 days. The increase in NO levels can promote relaxation of smooth muscle in blood vessels, which increases blood flow and improves cardiovascular and muscular health.

Primary author, Douglas S. Kalman, PhD, RD, CCRC, FACN, Director BD, Nutrition & Applied Clinical Trials at Miami Research Associates stated, “Nitrosigine, a new FDA-approved arginine-based molecule, has early and preliminary research that is deserving of further development.”

Michael Satow, President and Chief Executive Officer of Nutrition 21 commented, “We are immensely pleased with the new clinical results, confirming our pre-clinical studies, and furthermore supporting Nitrosigine™’s ability to significantly increase nitric oxide levels to optimize the benefits of rigorous workouts. Fitness-focused customers who want to get the most out of their training regimen, will appreciate that Nitrosigine™ is quickly absorbed by the body, taking effect in 30 minutes and lasting up to three hours. Nitrosigine™ has also been shown to significantly raise arginine and silicon levels – both important nutrients for cardiovascular performance.”

Consumer benefits directly linked to the study findings include:

    Nitrosigine™ significantly enhances nitric oxide levels
    Nitrosigine™ is a safe, bioavailable source of arginine and silicon
    Nitrosigine™ significantly increases plasma arginine levels in 30 minutes
    Nitrosigine™ significantly increases plasma arginine levels for up to 3 hours
    Nitrosigine™ significantly increases silicon levels for up to 1.5 hours

“Nutrition 21 is thrilled to have the human clinical study available as support for our NDI accepted, Nitrosigine™. Based on clinical and pre-clinical results, Nitrosigine™ demonstrates superiority over arginine as shown by increases in blood flow markers and silicon absorption. Nitrosigine™ is currently available in the retail channel in products such as, SuperPump® 3.0 and Razor8® and is in development in other finished goods. We anticipate continued high market interest with robust customer sales,” said Jim Kahn, Executive Director of National Sales at Nutrition 21.

About Experimental Biology 2014

The Experimental Biology (EB) meeting is a multi-society, interdisciplinary, biomedical, scientific meeting featuring plenary and award lectures, symposia, oral and poster sessions, a placement center, and an exhibit of scientific equipment, supplies, and publications. The meeting is one of the largest to date with over 14,000 attending scientists and researchers in the fields of anatomy, physiology, biochemistry, pathology, nutrition, and pharmacology. The Experimental Biology (EB) 2014 meeting will be held at the San Diego Convention Center, April 26 – 30, 2014.

For more information about the Experimental Biology 2014 annual meeting, please visit: http://www.experimentalbiology.org

About the Federation of American Societies for Experimental Biology (FASEB) Journal

The FASEB Journal is one of the world’s most cited biology journals. It is a preferred venue for the latest research reports and reviews of epigenetics, iRNA mechanics, histone acetylation, nitric oxide signaling, eicosanoid biochemistry, angiogenesis, tumor suppressor genes, apoptosis, cytoskeletal function, and human stem cell research. The journal publishes peer-reviewed, multidisciplinary original research articles, as well as editorials, reviews, and news of the life sciences.

For more information about the Federation of American Societies for Experimental Biology, please visit: http://www.FASEB.org

About Nutrition 21, LLC

Nutrition 21, a wholly owned subsidiary of JDS Therapeutics, is a leader in the nutritional supplement industry. The Company is a developer and marketer of efficacious, high-value, clinically substantiated ingredients for dietary supplements, medical foods and beverages, including CHROMAX® chromium picolinate and NITROSIGINE™ inositol-stabilized arginine silicate. In 2013 NITROSIGINE™ was accepted by the FDA as a New Dietary Ingredient (NDI).

With many years of biotechnology and pharmaceutical experience, the Company’s scientific platform has created unique, patentable products that are safe and clinically effective. Rigorous preclinical and clinical trials are a key part of its product development strategy to ensure product safety and consumer trust.

Nutrition 21 currently holds over 100 domestic and international issued and pending patents for products. Many support unique claims associated with, among others, glucose metabolism, weight management, brain health, cardiovascular health, and sports nutrition.

For more information, please visit: http://www.Nutrition21.com